Eckert and Ziegler

Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide. It operates in two segments, Medical and Isotope Products. The Medical segment offers small radioactive implants for the treatment of prostate cancer seeds; and eye application based on ruthenium-106 or iodine-125 for treating uveal melanoma. This segment also provides radiopharmaceuticals, laboratory equipment, hot cells, and services for radiopharmaceuticals, as well as eye applicators and prostate implants. The Isotope Products segment manufactures and sells radiation sources for imaging, measurement technology, material analysis, quality assurance, and environmental monitoring. This segment also offers calibration sources for medical imaging systems, and homeland security and radiometric level measurement products. The company was founded in 1992 and is headquartered in Berlin, Germany.

Eckert & Ziegler's mission is to provide innovative and reliable products for our customers, to create value for our shareholders and to ensure a stimulating and challenging working environment for our employees.

At Eckert & Ziegler, we strive to be a global leader in isotope-based solutions through our from dedication to customer service, commitment to quality and innovation, and our passion for excellence.

Eckert & Ziegler has achieved numerous awards and recognitions, including being named a “Future Maker” at the 2012 summer Olympics and a Digital Elite award winner at the 2013 Innovation Summit.